title: Lipoma preferred partner is a mechanosensitive protein regulated by nitric oxide in the heart.
abstract: Adaptor proteins play an important role in signaling pathways by providing a platform on which many other proteins can interact. Malfunction or mislocalization of these proteins may play a role in the development of disease. Lipoma preferred partner (LPP) is a nucleocytoplasmic shuttling adaptor protein. Previous work shows that LPP plays a role in the function of smooth muscle cells and in atherosclerosis. In this study we wanted to determine whether LPP has a role in the myocardium. LPP expression increased by 56% in hearts from pressure overload aortic-banded rats (p < 0.05 n = 4), but not after myocardial infarction, suggesting hemodynamic load regulates its expression. In vitro, LPP expression was 87% higher in cardiac fibroblasts than myocytes (p < 0.05 n = 3). LPP expression was downregulated in the absence of the actin cytoskeleton but not when microtubules were disassembled. We mechanically stretched cardiac fibroblasts using the Flexcell 4000 for 48 h (1 Hz, 5% maximum strain), which decreased total LPP total expression and membrane localization in subcellular fractions (p < 0.05, n = 5). However, L-NAME, an inhibitor of nitric oxide synthase (NOS), significantly upregulated LPP expression. These findings suggest that LPP is regulated by a complex interplay between NO and mechanical cues and may play a role in heart failure induced by increased hemodynamic load.
authors: Institute of Cardiovascular and Metabolic Research. The Schools of Biological Sciences and Pharmacy, University of Reading, Reading Berkshire, United Kingdom.
authors: Charlotte L
authors: CL
authors: Hooper
authors: Philip R
authors: PR
authors: Dash
authors: Samuel Y
authors: SY
authors: Boateng
keywords: Cytoskeleton; Fibroblasts; Heart failure; Hypertrophy; Mechanosensation; Myofilaments
references: Am J Physiol Cell Physiol. 2005 Jan;288(1):C30-8
references: 15371257
references: FASEB J. 2000 Jan;14(1):166-73
references: 10627291
references: Am J Physiol Cell Physiol. 2003 Sep;285(3):C674-85
references: 12760907
references: J Muscle Res Cell Motil. 2009;30(1-2):41-55
references: 19205907
references: Cancer Genet Cytogenet. 1998 Oct 1;106(1):18-23
references: 9772904
references: Trends Cell Biol. 2001 Feb;11(2):66-75
references: 11166214
references: Biochim Biophys Acta. 2001 Apr 23;1538(2-3):260-72
references: 11336797
references: Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H259-69
references: 16963613
references: Gene. 2011 Mar 1;473(2):67-75
references: 21145950
references: Genes Chromosomes Cancer. 2000 Dec;29(4):363-6
references: 11066083
references: J Cell Sci. 2003 Apr 1;116(Pt 7):1359-66
references: 12615977
references: Genomics. 1996 Aug 15;36(1):118-29
references: 8812423
references: Clin Exp Pharmacol Physiol. 2009 May;36(5-6):559-66
references: 19673940
references: Mol Biol Cell. 2000 Jan;11(1):117-29
references: 10637295
references: J Mol Cell Cardiol. 1998 Dec;30(12):2683-94
references: 9990539
references: Int J Med Microbiol. 2009 Apr;299(4):301-12
references: 18929503
references: J Biol Chem. 2006 Jun 9;281(23):16178-88
references: 16613855
references: Biochem Biophys Res Commun. 2009 Feb 6;379(2):368-73
references: 19111675
references: Am J Physiol. 1999 Jun;276(6):C1271-81
references: 10362589
references: J Mol Cell Cardiol. 2009 Oct;47(4):426-35
references: 19376126
references: Mol Cell Biol. 2006 Jun;26(12):4529-38
references: 16738319
references: Oncogene. 2012 Nov 8;31(45):4778-88
references: 22266854
references: Genes Dev. 2004 Oct 15;18(20):2518-28
references: 15489293
references: BMC Cancer. 2007 Oct 23;7:198
references: 17956604
references: Biochemistry. 1997 Nov 4;36(44):13677-81
references: 9354637